Close

Jump to:

  • Navigation
  • Content
  • Footer
WorldLabs hero image

WorldLabs

Follow

WorldLabs brings together innovators and organisations in an ecosystem that fosters innovation.

131%
 - 
Funded 29 Mar 2019
£400,000 target
£527,943 from 377 investors
More
Less

Business overview

Location LONDON, United Kingdom
Social media
Website www.worldlabs.org
Sectors SaaS/PaaS Digital Mixed B2B/B2C
Company number 10046861
Incorporation date 7 Mar 2016
More
Less

Investment summary

Type Equity
Valuation (pre-money) £4.1M
Equity offered 11.35%
Tax relief

EIS

  • Idea
  • Team
  • Updates
  • Investors 377
  • Discussion
  • Documents

Idea

Introduction

WorldLabs is a digital global innovation platform that helps fast-track the development of innovative ideas.

Billions of pounds are invested each year in Europe alone to support innovation and drive economic growth. Yet, funding, resources, collaborators and support are still fragmented and hard to reach.

WorldLabs aims to change that. We streamline how people engage with funding and collaboration opportunities by bringing together innovators and organisations - within academic, public and private sectors - in an ecosystem that fosters innovation.

Since our launch in mid-2018, thousands of innovators around the globe have already joined WorldLabs to apply for hundreds of thousands of pounds in funding contests and to connect with other like-minded changemakers.

We have already established partnerships with leading organisations around the world, such as Cambridge University, UCL, VCs, incubators and more.

Intended impact

Innovation is essential for the success of any organisation.

More organisations, such as corporates, universities, funding bodies and incubators, are using new strategies to innovate, stay competitive and grow. These involve sharing knowledge both internally and with other institutions. Through market research, we have seen that organisations supporting innovators want to be more connected to one another and their members.

We believe WorldLabs is in the right place at the right time. We capitalise on this market need by providing a digital platform that helps foster innovation on a global scale.

WorldLabs provides a unified ecosystem where innovators can connect to thousands of ventures, raise visibility for their initiative, and easily discover and apply for funding and collaboration opportunities matched to them.

At the same time, organisations can engage and manage their members, streamline contest management and tap into a global community of innovators. All in one place.

Substantial accomplishments to date

Q2 2017 - Q2 2018:
• Conducted market research and built the first software prototype.
• Completed seed round raising nearly £0.5 million.
• Entrepreneur and Cambridge University Professor Daping Chu joined the advisory board.
• Built a passionate team with a wealth of experience from other startups and large organisations (Nestle, Argos, Amazon, Disney, Virgin Media).

Q3 2018:
• Launched WorldLabs to the public.
• Featured in The Times, Business Weekly and interviewed on the radio.
• Partnered with Cambridge Consulting Network and launched their innovation competitions.
• Dr David Brown, co-inventor of Viagra, joined the advisory board.
• Cambridge Engineering Department hosted their funding contests on the platform.
• Reached 2,000+ users and 200+ live projects in less than 3 months.

Q4 2018:
• Launched private beta programme for new B2B features.
• Signed partnerships with Cambridge University Judge Business School.
• Partnered with UCL Innovation & Enterprise and Lime HK.
• Reached almost 7,000 users and 1,000+ live projects.
• Co-inventor of Viagra to launch Sepsis Challenge to crowdsource new treatments for sepsis.
• Launched the Elevating Ideas 2018 Conference (www.worldlabs.org/Ei18), attended by 500+ investors and entrepreneurs and supported by high-profile industry leaders, venture capitalists, million-pound startup founders and large organisations.
• Initiated partnership talks with leading organisations with 100,000s of members, such as the UK Catapults, the University of Wisconsin (USA) and more.

Monetisation strategy

WorldLabs offers multiple B2B and B2C revenue streams (www.worldlabs.org/pricing) targeted at organisations (public and private institutions, such as universities, incubators and accelerators) and users (entrepreneurs and innovators at our B2B organisations and beyond).

• Community Management (B2B - monthly subscription, www.worldlabs.org/community): Organisations can use a highly customisable software platform to build, manage and engage their community of innovators.
• Contest Management (B2B - initial fee plus monthly subscription, www.worldlabs.org/contest): Organisations can use integrated tools to simplify contest management and tap into our global community of innovators.
• Marketplace (B2B & B2C - fee per ad, www.worldlabs.org/marketplace): Users can post ads for what they are offering and looking for: talent, services, products or funding opportunities.

Other revenue opportunities we will launch include Boost (B2B & B2C - fee per ad), to let users create highly targeted ads, and commission-based services, to connect service providers, such as investors, lawyers and consultants, to innovators on WorldLabs.

Use of proceeds

This funding round will help accelerate our growth to make WorldLabs the go-to platform for innovators and organisations serving innovators worldwide.

The major focus areas covered with the proceeds raised are:

• Team: we will hire key management roles to support increased acquisitions and to help fuel sales to expand into more universities and institutions worldwide.
• Product Development: we will build a mobile app and new sophisticated features that will help streamline the innovation process and include machine learning.
• Marketing and Brand Identity: we will support our growth by boosting targeted marketing campaigns, and by engaging influencers to empower more innovators.

Our pledge:
Our commitment to all of our investors is to produce regular updates, manage our cash flow conscientiously, stay lean, always be transparent, and continue to make a positive impact on the world by breaking down barriers to societal and technological advancement.

Notices

Please note, WorldLabs currently has an outstanding directors loan for £71,694.48. This loan is interest-free and will only be repaid once the company is profitable.

Open an account to get access to the team members of WorldLabs

Sign up

Already have an account? Log in

To comply with financial regulations, we can only show full campaign details to registered users.

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Share on:

Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future.

This campaign for WorldLabs has been approved by Seedrs Limited (trading as Republic Europe) ("Republic Europe", "us" or "we"), as of 29 December 2018 as a financial promotion. Republic Europe is authorised and regulated by the Financial Conduct Authority with firm reference number 550317. In approving this campaign, Republic Europe has concluded that the information, taken as a whole, is "fair, clear and not misleading." This means that for factual statements we have reviewed evidence of their accuracy, and that for aspirational statements we believe they are phrased appropriately in light of their speculative nature. You should note that in the case of factual statements, the evidence we review is provided by the business, and we do not audit it, which means that we may not be able to identify forged or altered evidence. You should further note that in the case of aspirational statements, the nature of the type of businesses presented on the Republic Europe platform is such that they are likely to have high ambitions, and we may approve statements that convey those ambitions even where we do not believe, or we do not have a view on whether it is likely, that they will be fully realised. The pre-money valuation and investment sought in the campaign are those set by the business: they are not reviewed or established by us, and the valuation is not an independent view of what the business is worth. Given the nature and type of businesses presented on the Republic Europe platform, it is possible that the business has very little cash remaining prior to receiving this investment, and the investment sought may be necessary for the business's on-going existence.

Republic Europe does not make investment recommendations to you. No communications from Republic Europe, through this website or any other medium, should be construed as an investment recommendation. Further, nothing on this website shall be considered an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. Republic Europe does not provide legal, financial or tax advice of any kind. If you have any questions with respect to legal, financial or tax matters relevant to your interactions with Republic Europe, you should consult a professional adviser.

Tax Relief (SEIS)

This business is eligible for SEIS relief - providing qualifying investors with income tax relief of 50% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Tax Relief (EIS)

This business is eligible for EIS relief - providing qualifying investors with income tax relief of 30% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Valuation (pre-money)

Valuation rounded from £4,106,563

This is the fully-diluted pre-money valuation of the business (i.e. before the new investment comes in and including issued options and other equity interests). In contrast, the post-money valuation is based on inclusion of the new investment in the value.

It is calculated as the pre-money valuation plus the amount of new investment. e.g. If Company A is ascribed a pre-money valuation of £1,200,000 by prospective investors investing £300,000, its post-money valuation is £1,500,000.

The investee business is responsible for setting its own valuation, it has not been prescribed by Seedrs.

Pitch type

Investing in a regular equity campaign is the simplest and most common way to invest in a startup. You decide which business you want to invest in, and if the campaign hits its funding target then you will become one of their shareholders. As the company becomes more valuable, so do your shares; allowing you the opportunity to share in the future success of the business.

Learn more about pitch type on Seedrs

Equity Offered

The equity offered is the percentage of the company’s shares being issued in return for the amount of investment raised.

When the amount raised is less than 100%, the equity offered is based on the target raise. Once the company has raised over 100% it is based on the total raised.

In some scenarios, entrepreneurs may accept additional direct investment after closing their Seedrs campaign. Provided this is within 6 months of the closing and on the same terms, we do not typically offer pre-emption rights on that extra investment (where you have the opportunity to invest again to maintain your percentage shareholding).

Learn more about investing and pre-emption rights.

Warning

You are following a link outside of europe.republic.com.

None of the information in constitutes part of the campaign and it has not been approved or reviewed by Seedrs.

ContinueCancel